DK3394053T3 - (4-hydroxy-2-phenyl-1,3-thiazol-5-yl)-methanonderivater som trpm8-antagonister - Google Patents
(4-hydroxy-2-phenyl-1,3-thiazol-5-yl)-methanonderivater som trpm8-antagonister Download PDFInfo
- Publication number
- DK3394053T3 DK3394053T3 DK16823231T DK16823231T DK3394053T3 DK 3394053 T3 DK3394053 T3 DK 3394053T3 DK 16823231 T DK16823231 T DK 16823231T DK 16823231 T DK16823231 T DK 16823231T DK 3394053 T3 DK3394053 T3 DK 3394053T3
- Authority
- DK
- Denmark
- Prior art keywords
- thiazol
- hydroxy
- phenyl
- methanone derivatives
- trpm8 antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15201788.5A EP3184524A1 (en) | 2015-12-21 | 2015-12-21 | 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists |
| PCT/EP2016/081567 WO2017108632A1 (en) | 2015-12-21 | 2016-12-16 | 4-hydroxy-2-phenyl-1,3-thiazol-5-yl methanone derivatives as trpm8 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3394053T3 true DK3394053T3 (da) | 2019-11-18 |
Family
ID=54883947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16823231T DK3394053T3 (da) | 2015-12-21 | 2016-12-16 | (4-hydroxy-2-phenyl-1,3-thiazol-5-yl)-methanonderivater som trpm8-antagonister |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10246448B2 (da) |
| EP (2) | EP3184524A1 (da) |
| JP (1) | JP6908610B2 (da) |
| KR (1) | KR20180095818A (da) |
| CN (1) | CN108699053B (da) |
| AU (1) | AU2016378108B9 (da) |
| CY (1) | CY1122312T1 (da) |
| DK (1) | DK3394053T3 (da) |
| EA (1) | EA037845B1 (da) |
| ES (1) | ES2757324T3 (da) |
| HK (1) | HK1257896B (da) |
| HR (1) | HRP20192008T1 (da) |
| HU (1) | HUE046284T2 (da) |
| LT (1) | LT3394053T (da) |
| PT (1) | PT3394053T (da) |
| RS (1) | RS59475B1 (da) |
| SI (1) | SI3394053T1 (da) |
| WO (1) | WO2017108632A1 (da) |
| ZA (1) | ZA201803300B (da) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2015531A (en) | 1932-07-25 | 1935-09-24 | Champion Paper & Fibre Co | Roll coating machine |
| WO2006040136A1 (en) | 2004-10-13 | 2006-04-20 | Bayer Healthcare Ag | Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonists for the treatment of urological disorder |
| WO2007017094A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted benzyloxy-phenylmethylcarbamate derivatives |
| WO2007017092A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 4-benzyloxy-benzoic acid amide derivatives |
| WO2007017093A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 2-benzyloxy-benzoic acid amide derivatives |
| WO2007080109A1 (en) | 2006-01-16 | 2007-07-19 | Bayer Healthcare Ag | Substituded benzyloxy-phenylmethylurea derivatives |
| EP2029614B1 (en) | 2006-05-10 | 2013-01-23 | Janssen Pharmaceutica, N.V. | Cold menthol receptor-1 antagonists |
| WO2009012430A1 (en) * | 2007-07-18 | 2009-01-22 | Janssen Pharmaceutica N.V. | Sulfonamides as trpm8 modulators |
| WO2010103381A1 (en) | 2009-03-13 | 2010-09-16 | Glenmark Pharmaceuticals S.A. | Spirocyclic piperidine derivatives as trpm 8 modulators |
| KR20140071518A (ko) | 2009-05-01 | 2014-06-12 | 라퀄리아 파마 인코포레이티드 | Ｔｒｐｍ8 길항제로서의 설파모일 벤조산 유도체 |
| US20130079348A1 (en) * | 2010-03-03 | 2013-03-28 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| ES2377785B2 (es) | 2010-09-08 | 2012-09-26 | Universidad Miguel Hernández De Elche | Composición farmacéutica para el tratamiento del ojo seco. |
| EP2481727A1 (en) * | 2011-01-28 | 2012-08-01 | Dompe S.p.A. | TRPM8 receptor antagonists |
| LT2793883T (lt) * | 2011-12-19 | 2018-08-10 | DompƩ farmaceutici s.p.a. | Trpm8 antagonistai |
| US9458092B2 (en) * | 2013-05-08 | 2016-10-04 | Kissei Pharmaceutical Co., Ltd. | α-Substituted glycinamide derivative |
| SI3157918T1 (sl) * | 2014-06-23 | 2019-05-31 | Dompe Farmaceutici S.P.A. | 2-aril-4-hidroksi-1,3-tiazolni derivati, uporabni kot inhibitorji TRPM8 pri zdravljenju nevralgije, bolečine, KOPB in astme |
-
2015
- 2015-12-21 EP EP15201788.5A patent/EP3184524A1/en not_active Withdrawn
-
2016
- 2016-12-16 LT LT16823231T patent/LT3394053T/lt unknown
- 2016-12-16 CN CN201680073977.3A patent/CN108699053B/zh active Active
- 2016-12-16 SI SI201630487T patent/SI3394053T1/sl unknown
- 2016-12-16 EP EP16823231.2A patent/EP3394053B1/en active Active
- 2016-12-16 EA EA201891503A patent/EA037845B1/ru unknown
- 2016-12-16 RS RS20191415A patent/RS59475B1/sr unknown
- 2016-12-16 KR KR1020187016746A patent/KR20180095818A/ko not_active Application Discontinuation
- 2016-12-16 ES ES16823231T patent/ES2757324T3/es active Active
- 2016-12-16 US US16/061,850 patent/US10246448B2/en active Active
- 2016-12-16 JP JP2018532605A patent/JP6908610B2/ja active Active
- 2016-12-16 DK DK16823231T patent/DK3394053T3/da active
- 2016-12-16 WO PCT/EP2016/081567 patent/WO2017108632A1/en active Application Filing
- 2016-12-16 PT PT168232312T patent/PT3394053T/pt unknown
- 2016-12-16 AU AU2016378108A patent/AU2016378108B9/en active Active
- 2016-12-16 HU HUE16823231A patent/HUE046284T2/hu unknown
-
2018
- 2018-05-17 ZA ZA2018/03300A patent/ZA201803300B/en unknown
-
2019
- 2019-01-08 HK HK19100257.7A patent/HK1257896B/zh unknown
- 2019-11-06 HR HRP20192008TT patent/HRP20192008T1/hr unknown
- 2019-11-11 CY CY20191101183T patent/CY1122312T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI3394053T1 (sl) | 2019-12-31 |
| WO2017108632A1 (en) | 2017-06-29 |
| HK1257896B (zh) | 2020-06-19 |
| US10246448B2 (en) | 2019-04-02 |
| US20180319785A1 (en) | 2018-11-08 |
| HRP20192008T1 (hr) | 2020-02-07 |
| ES2757324T3 (es) | 2020-04-28 |
| AU2016378108B9 (en) | 2021-01-28 |
| AU2016378108A1 (en) | 2018-06-21 |
| JP6908610B2 (ja) | 2021-07-28 |
| JP2018538334A (ja) | 2018-12-27 |
| HUE046284T2 (hu) | 2020-02-28 |
| EP3394053A1 (en) | 2018-10-31 |
| LT3394053T (lt) | 2019-12-10 |
| RS59475B1 (sr) | 2019-12-31 |
| ZA201803300B (en) | 2019-07-31 |
| AU2016378108B2 (en) | 2020-12-17 |
| CN108699053B (zh) | 2022-01-14 |
| EP3184524A1 (en) | 2017-06-28 |
| PT3394053T (pt) | 2019-10-31 |
| EA037845B1 (ru) | 2021-05-27 |
| CN108699053A (zh) | 2018-10-23 |
| EA201891503A1 (ru) | 2019-01-31 |
| EP3394053B1 (en) | 2019-08-21 |
| KR20180095818A (ko) | 2018-08-28 |
| CY1122312T1 (el) | 2021-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3523287T3 (da) | Benzo[b]thiophenforbindelser som sting-agonister | |
| DK3472167T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3461821T3 (da) | Indolcarboxamidforbindelser, der er brugbar som kinasehæmmere | |
| DK3355884T3 (da) | Tetrahydro-1h-pyrido[3,4-b]indol-antiøstrogenlægemidler | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| BR112017027339A2 (pt) | derivados de piperidina 1,4-substituída | |
| DK3357919T3 (da) | Aromatiske heterocykliske forbindelser som antiinflammatoriske forbindelser | |
| DK3356345T3 (da) | Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer | |
| DK3094631T3 (da) | Pyrimidinyloxybenzenderivater som herbicider | |
| DK3253762T3 (da) | 9h-pyrrolo-dipyridinderivater. | |
| DK2989092T3 (da) | Quinazolinonderivater, der er anvendelige som fgfr-kinasemodulatorer | |
| DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
| DK3003038T3 (da) | 2h-1,2,3-triazolderivater som inhibitorer af fibrose | |
| DK3250586T3 (da) | Hidtil ukendte proteiner, som er specifikke for angiogenese | |
| DK3256462T3 (da) | Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
| BR112017001387A2 (pt) | alargador. | |
| DK3672951T3 (da) | Quinoxalinderivater som adenosinreceptorantagonister | |
| BR112017001388A2 (pt) | alargador. | |
| BR112017001386A2 (pt) | alargador. | |
| DK3153508T3 (da) | Naphthofuranderivater til anvendelse som anticancermidler | |
| DK3368519T3 (da) | Hidtil ukendte, heterocykliske antiøstrogener |